Clinical Trial Update: MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02) [NA]

View source ↗

Summary

Clinical trial registry update indicates recruitment for MR-linac guided ultra-hypofractionated radiotherapy protocols SMART-P01 and SMART-P02 for prostate canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Prostate Cancer, Radiotherapy Side Effect | NA | Status: RECRUITING